{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:52:02Z","timestamp":1787615522132,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1136\/annrheumdis-2011-200637","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T02:18:59Z","timestamp":1324001939000},"page":"948-954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study"],"prefix":"10.1016","volume":"71","author":[{"given":"Marloes W","family":"Heijstek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter GM","family":"van Gageldonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy AM","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-200637_bib1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJMra011223","article-title":"Vaccines and vaccination","volume":"345","author":"Ada","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2011-200637_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(94)92091-5","article-title":"Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992\u201393","volume":"344","author":"Oostvogel","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2011-200637_bib3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib5","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.vaccine.2008.02.028","article-title":"Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000\u20132005","volume":"26","author":"Atrasheuskaya","year":"2008","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib6","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200637_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/berh.2001.0226","article-title":"Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis","volume":"16","author":"Fessler","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200637_bib8","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0950268898001587","article-title":"Immunosurveillance and the evaluation of national immunization programmes: a population-based approach","volume":"121","author":"De Melker","year":"1998","journal-title":"Epidemiol Infect"},{"key":"10.1136\/annrheumdis-2011-200637_bib10","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200637_bib11","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/jcm.30.8.2139-2144.1992","article-title":"Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps","volume":"30","author":"Harmsen","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1136\/annrheumdis-2011-200637_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1017\/S0950268803008641","article-title":"Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay","volume":"131","author":"van den Hof","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1136\/annrheumdis-2011-200637_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1017\/S0950268807008266","article-title":"Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia","volume":"135","author":"Tischer","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1136\/annrheumdis-2011-200637_bib14","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/S0264-410X(03)00490-0","article-title":"Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay","volume":"21","author":"van den Hof","year":"2003","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S0950268899004173","article-title":"The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella","volume":"125","author":"Andrews","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1136\/annrheumdis-2011-200637_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1136\/annrheumdis-2011-200637_bib17","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1016\/j.vaccine.2010.09.036","article-title":"High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study","volume":"28","author":"Steens","year":"2010","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/CVI.00096-10","article-title":"External quality assessment for the determination of diphtheria antitoxin in human serum","volume":"17","author":"Di Giovine","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1136\/annrheumdis-2011-200637_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1136\/annrheumdis-2011-200637_bib20","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/S0264-410X(00)00125-0","article-title":"European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays","volume":"18","author":"von Hunolstein","year":"2000","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(02)00587-X","article-title":"Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b","volume":"21","author":"de Melker","year":"2003","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib22","first-page":"356","article-title":"[Childhood vaccinations anno 2004. I. Effectiveness and acceptance of the Dutch National Vaccination Programme]","volume":"148","author":"R\u00fcmke","year":"2004","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1136\/annrheumdis-2011-200637_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200637_bib24","first-page":"2555","article-title":"Specific antibody response after influenza immunization in systemic lupus erythematosus","volume":"29","author":"Abu-Shakra","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200637_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-88-6-729","article-title":"Influenza immunization in systemic lupus eruthematosus. A double-blind trial","volume":"88","author":"Williams","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2011-200637_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.61.7.623","article-title":"Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis","volume":"61","author":"Elkayam","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/ard.2005.036434","article-title":"Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers","volume":"65","author":"Fomin","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338043","article-title":"Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus","volume":"34","author":"Elkayam","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib29","first-page":"181","article-title":"Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid","volume":"5","author":"Kashef","year":"2008","journal-title":"Iran J Immunol"},{"key":"10.1136\/annrheumdis-2011-200637_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-88-6-786","article-title":"Influenza vaccination of patients with systemic lupus erythematosus","volume":"88","author":"Ristow","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2011-200637_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10067-010-1373-y","article-title":"Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety","volume":"29","author":"Wiesik-Szewczyk","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200637_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0090-1229(91)90086-P","article-title":"Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation","volume":"59","author":"ter Borg","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/annrheumdis-2011-200637_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-200637_bib34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1136\/annrheumdis-2011-200637_bib35","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/infdis\/172.6.1591","article-title":"Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination","volume":"172","author":"Ward","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib36","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s10875-010-9420-7","article-title":"Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen","volume":"30","author":"Viana","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1136\/annrheumdis-2011-200637_bib37","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1086\/588195","article-title":"Immune responses to mumps vaccine in adults who were vaccinated in childhood","volume":"197","author":"Hanna-Wakim","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1136\/annrheumdis-2011-200637_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2009.0068","article-title":"Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity","volume":"22","author":"Tosh","year":"2009","journal-title":"Viral Immunol"},{"key":"10.1136\/annrheumdis-2011-200637_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0950268899002939","article-title":"Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination","volume":"123","author":"de Haas","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1136\/annrheumdis-2011-200637_bib40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/0961203310397409","article-title":"Vaccine antibodies and T- and B-cell interaction in juvenile systemic lupus erythematosus","volume":"20","author":"Miyamoto","year":"2011","journal-title":"Lupus"},{"key":"10.1136\/annrheumdis-2011-200637_bib41","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1016\/j.vaccine.2008.06.057","article-title":"Vaccine immunogenetics: bedside to bench to population","volume":"26","author":"Poland","year":"2008","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib42","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/S0264-410X(00)00468-0","article-title":"Twin studies of immunogenicity \u2013 determining the genetic contribution to vaccine failure","volume":"19","author":"Tan","year":"2001","journal-title":"Vaccine"},{"key":"10.1136\/annrheumdis-2011-200637_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1546-0096-6-11","article-title":"A comprehensive review of the genetics of juvenile idiopathic arthritis","volume":"6","author":"Prahalad","year":"2008","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1136\/annrheumdis-2011-200637_bib44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/rheumatology\/41.10.1183","article-title":"Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients","volume":"41","author":"Thomson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"10.1136\/annrheumdis-2011-200637_bib45","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s10875-008-9182-7","article-title":"Autoimmune manifestations in common variable immunodeficiency","volume":"28","author":"Cunningham-Rundles","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1136\/annrheumdis-2011-200637_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/08916930902832306","article-title":"Do B cells play a role in the pathogenesis of juvenile idiopathic arthritis","volume":"42","author":"Morbach","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1136\/annrheumdis-2011-200637_bib47","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/art.23599","article-title":"Premature aging of the immune system in children with juvenile idiopathic arthritis","volume":"58","author":"Prelog","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1136\/annrheumdis-2011-200637_bib48","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jcpa.2009.10.002","article-title":"Fading immune protection in old age: vaccination in the elderly","volume":"142","author":"Grubeck-Loebenstein","year":"2010","journal-title":"J Comp Pathol"},{"key":"10.1136\/annrheumdis-2011-200637_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012144","article-title":"Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine","volume":"5","author":"de Voer","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724188176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724188176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-200637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:53:08Z","timestamp":1737528788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724188176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0003496724188176"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200637","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}